Document ID: docfile:8bfa2371-52f5-4f59-a782-01dd4c09acf5
Source Database: euc_mergers
Source URL: https://ec.europa.eu/competition/mergers/cases/additional_data/m7919_1269_5.pdf
Title: SANOFI / BOEHRINGER INGELHEIM CONSUMER HEALTHCARE BUSINESS
Date: 2017-05-03T00:00:00.000+02:00
Metadata: {"caseNumber": "M.7919", "caseInstrument": "M", "caseTitle": "SANOFI / BOEHRINGER INGELHEIM CONSUMER HEALTHCARE BUSINESS", "caseLastDecisionDate": "2017-05-02T22:00:00.000Z", "caseCompanies": ["SANOFI / BOEHRINGER INGELHEIM CONSUMER HEALTHCARE BUSINESS"]}

# **MONITORING TRUSTEE IN CASE M.7919 – Sanofi / Boehringer Ingelheim Consumer Healthcare Business**

On 12 August 2016 the Commission approved the appointment of:

Grant Thornton UK LLP 30 Finsbury Square London EC2P 2YU United Kingdom Fax: +44(0)20 7728 2522 E-mail : mark.r.byers@uk.gt.com, craig.reed@uk.gt.com

as Monitoring Trustee in the above-mentioned case.

The role of the Monitoring Trustee is to monitor the compliance of Sanofi with the Commitments attached to the Commission's Decision of 4 August 2016 and to report to the Commission thereon.

Third parties who have queries in relation to the Commitments may contact the Trustee through the above contact details.

The foregoing is without prejudice to the Commission's jurisdiction to oversee the implementation of the Commitments attached to its Decision.